Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of orlistat on weight loss, hormonal and metabolic profiles in women with polycystic ovarian syndrome: a randomized double-blind placebo-controlled trial.

× No keyword cloud information.

27 in total

Review 1. Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss.

Authors: P Ravn; A G Haugen; D Glintborg
Journal: Minerva Endocrinol Date: 2013-03 Impact factor: 2.184

2. Orlistat 60 mg reduces visceral adipose tissue: a 24-week randomized, placebo-controlled, multicenter trial.

Authors: Steven R Smith; Kaj S Stenlof; Frank L Greenway; John McHutchison; Susan M Schwartz; Vidhu B Dev; Evan S Berk; Roxanne Kapikian
Journal: Obesity (Silver Spring) Date: 2011-06-30 Impact factor: 5.002

3. Role of diet in the treatment of polycystic ovary syndrome.

Authors: Crystal C Douglas; Barbara A Gower; Betty E Darnell; Fernando Ovalle; Robert A Oster; Ricardo Azziz
Journal: Fertil Steril Date: 2006-03 Impact factor: 7.329

Review 4. Polycystic ovary syndrome.

Authors: S Franks
Journal: N Engl J Med Date: 1995-09-28 Impact factor: 91.245

5. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.

Authors: Dimitrios Panidis; Konstantinos Tziomalos; Efstathios Papadakis; Panagiotis Chatzis; Eleni A Kandaraki; Elena A Tsourdi; Ilias Katsikis
Journal: Clin Endocrinol (Oxf) Date: 2013-08-28 Impact factor: 3.478

6. Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome.

Authors: V Jayagopal; E S Kilpatrick; S Holding; P E Jennings; S L Atkin
Journal: J Clin Endocrinol Metab Date: 2004-11-09 Impact factor: 5.958

7. Androgen circle of polycystic ovary syndrome.

Authors: Roy Homburg
Journal: Hum Reprod Date: 2009-03-11 Impact factor: 6.918

8. A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients.

Authors: M Parillo; A A Rivellese; A V Ciardullo; B Capaldo; A Giacco; S Genovese; G Riccardi
Journal: Metabolism Date: 1992-12 Impact factor: 8.694

9. Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss.

Authors: S Jacob; M Rabbia; M K Meier; J Hauptman
Journal: Diabetes Obes Metab Date: 2009-01-22 Impact factor: 6.577

10. Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis.

Authors: K Johansson; K Neovius; S M DeSantis; S Rössner; M Neovius
Journal: Obes Rev Date: 2009-05-12 Impact factor: 9.213

3 in total

1. The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.

Authors: Mohamed Abdel-Maboud; Amr Menshawy; Elfatih A Hasabo; Mohamed Ibrahim Abdelraoof; Mohamed Alshandidy; Muhammad Eid; Esraa Menshawy; Oumaima Outani; Ahmed Menshawy
Journal: PLoS One Date: 2021-07-19 Impact factor: 3.240

2. The effect of orlistat versus metformin on body composition and insulin resistance in obese premenopausal women: 3-month randomized prospective open-label study.

Authors: Magdalena Kujawska-Łuczak; Katarzyna Musialik; Monika Szulińska; Ewelina Swora-Cwynar; Angelina Kargulewicz; Małgorzata Grzymisławska; Danuta Pupek-Musialik; Paweł Bogdański
Journal: Arch Med Sci Date: 2016-08-29 Impact factor: 3.318

3. Strong inhibitory activities and action modes of lipopeptides on lipase.

Authors: Mei-Chun Chen; Tian-Tian Liu; Jie-Ping Wang; Yan-Ping Chen; Qing-Xi Chen; Yu-Jing Zhu; Bo Liu
Journal: J Enzyme Inhib Med Chem Date: 2020-12 Impact factor: 5.051

3 in total